Absology Co., Ltd. is a South Korean in-vitro diagnostics (IVD) company founded in 2017 and headquartered in Anyang, Gyeonggi-do. It designs and manufactures point-of-care immunoassay analyzers and the reagent cartridges that run on them, built on microfluidic immunoassay and photo-oxidation-induced fluorescence amplification chemistry. Its Absol analyzer line runs rapid and ultra-sensitive quantitative blood tests — testosterone, vitamin D, PSA, TSH, free T4, PCT, cortisol and cardiac markers — for human and companion-animal use, with stated research programs in anti-cancer therapy monitoring, cardiovascular disease and neurodegenerative disease. Absology is a hardware and consumables manufacturer rather than a software vendor, and no public developer program, API, SDK or machine-readable contract has been found on its corporate site or in any public package registry or code host.
Absology is profiled on the APIs.io network. Tagged areas include Company, Healthcare, Medical Devices, Diagnostics, and In Vitro Diagnostics.
Regulatory Posture applies to this provider. Its tags matched the
Health regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/absology: open an issue to ask a question, or submit a pull request to add artifacts.
Submit an artifact on GitHub — free →Manage your own listing — the Influence plan, $499/mo →
aid: absology
name: Absology
description: Absology Co., Ltd. is a South Korean in-vitro diagnostics (IVD) company founded in 2017 and headquartered in
Anyang, Gyeonggi-do. It designs and manufactures point-of-care immunoassay analyzers and the reagent cartridges that run
on them, built on microfluidic immunoassay and photo-oxidation-induced fluorescence amplification chemistry. Its Absol analyzer
line runs rapid and ultra-sensitive quantitative blood tests — testosterone, vitamin D, PSA, TSH, free T4, PCT, cortisol
and cardiac markers — for human and companion-animal use, with stated research programs in anti-cancer therapy monitoring,
cardiovascular disease and neurodegenerative disease. Absology is a hardware and consumables manufacturer rather than a
software vendor, and no public developer program, API, SDK or machine-readable contract has been found on its corporate
site or in any public package registry or code host.
url: https://raw.githubusercontent.com/api-evangelist/absology/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
specificationVersion: '0.20'
created: '2026-09-06'
modified: '2026-09-06'
tags:
- Company
- Healthcare
- Medical Devices
- Diagnostics
- In Vitro Diagnostics
- Point of Care
- Laboratory
- South Korea
tags_raw:
- Company
- Health Care
- Medical Devices
- Diagnostics
- In-Vitro Diagnostics
- Point Of Care
- Laboratory
- South Korea
apis: []
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
common:
- type: DomainSecurity
url: security/absology-domain-security.yml
- type: LLMsTxt
url: llms/absology-llms.txt
- type: Website
url: https://www.absology.co.kr/
- type: LinkedIn
url: https://www.linkedin.com/company/absology-co-ltd
x-enrichment:
date: '2026-09-06'
status: minimal
artifacts_added: 3
pass: local-v3
x-coverage:
state: blocked
reason: bot-challenge
detail: Every path on absology.co.kr and www.absology.co.kr — homepage, robots.txt, /openapi.json and the whole /.well-known/
list — answers HTTP 200 with the same Korean CUPID slowAES anti-bot interstitial ("Please prove that you are human") instead
of the page, so the corporate site could not be read and no claim about Absology's developer surface can be made from
it; we do not evade challenges.
evidence:
- url: https://absology.co.kr/
status: 200
- url: https://www.absology.co.kr/.well-known/security.txt
status: 200
- url: https://absology.co.kr/.well-known/absology-negative-control-7f3ab91c.json
status: 200
- url: https://absology.co.kr/openapi.json
status: 200
checked: '2026-09-06'
Discovery needs no key. Ratings and market analysis are Pro.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.
Kin Score
How this is scored →